<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-911</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>ИНТЕРЛЕЙКИН-10 КАК ПОТЕНЦИАЛЬНЫЙ РЕГУЛЯТОР PD-1-B7-H1-ОПОСРЕДУЕМОЙ ЦИТОТОКСИЧЕСКОЙ АКТИВНОСТИ ДЕНДРИТНЫХ КЛЕТОК</article-title><trans-title-group xml:lang="en"><trans-title>INTERLEUKIN-10 REGULATES PD-1-B7-H1-MEDIATED CYTOTOXIC ACTIVITY OF DENDRITIC CELLS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сахно</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sakhno</surname><given-names>L. V.</given-names></name></name-alternatives><email xlink:type="simple">rtjab@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тихонова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tikhonova</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Леплина</surname><given-names>О. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Leplina</surname><given-names>O. Yu.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Останин</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostanin</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Черных</surname><given-names>Е. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernykh</surname><given-names>E. R.</given-names></name></name-alternatives><email xlink:type="simple">ct_lab@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ клинической иммунологии СО РАМН</institution></aff><aff xml:lang="en"><institution>Research Institute of Clinical Immunology SB RAMS</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>28</day><month>05</month><year>2012</year></pub-date><volume>0</volume><issue>3(2)</issue><fpage>170</fpage><lpage>174</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сахно Л.В., Тихонова М.А., Леплина О.Ю., Останин А.А., Черных Е.Р., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Сахно Л.В., Тихонова М.А., Леплина О.Ю., Останин А.А., Черных Е.Р.</copyright-holder><copyright-holder xml:lang="en">Sakhno L.V., Tikhonova M.A., Leplina O.Y., Ostanin A.A., Chernykh E.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/911">https://www.actabiomedica.ru/jour/article/view/911</self-uri><abstract><p>Целью настоящей работы являлось сравнительное исследование фенотипических и функциональных свойств дендритных клеток (ДК) здоровых доноров и больных туберкулезом легких (ТБ), а также влияние экзогенного IL-10, добавляемого в процессе генерации ДК, на фенотип и апоптоз-индуцирующую активность ДК здоровых доноров. Было обследовано 60 больных туберкулезом легких, различающихся по уровню ответа на туберкулиновый очищенный белковый дериват (PPD) и 40 здоровых доноров крови. Установлено, что у больных ТБ дендритные клетки, генерированные in vitro из моноцитов крови в присутствии GM-CSF+IFN-α, характеризуются повышенной экспрессией В7-Н1, высоким уровнем продукции IL-10 и низкой аллостимуляторной активностью в СКЛ. В нашем исследовании была выявлена положительная взаимосвязь между эндогенной продукцией IL-10 и экспрессией B7-H1 в общей группе обследованных. Продемонстрировано, что добавление IL-10 в процессе генерации ДК здоровых доноров приводило к повышению содержания ДК экспрессирующих B7-H1, снижению их аллостимуляторной активности и усилению проапоптогенной активности дендритных клеток в СКЛ.</p></abstract><trans-abstract xml:lang="en"><p>In this investigation the phenotypic and functional properties of healthy donor and patient with pulmonary tuberculosis (PT) dendritic cells (DCs) were characterized. We also studied the influence of IL-10 on the phenotype and apoptosis-inducing activity of healthy donor DCs. 60 patients with pulmonary tuberculosis with different proliferative response to antigens of M. tuberculosis (purified protein derivative, PPD) and 40 healthy donors were enrolled in this study. It was revealed that DCs, generated in vitro from PT patient's blood monocytes with GM-CSF+IFN-α, were characterized by increased B7-H1 expression, up-production of IL-10 and reducing of allostimulatory activity in mixed lymphocyte culture (MLC). The endogenous IL-10 production by DCs was correlated with expression of B7-H1 in the general group of persons. It was revealed that addition of IL-10 to semi-mature DCs of healthy donor results in increasing of B7-H1 expression, diminishing of allostimulatory activity and enlargement of pro-apoptogenic activity of DCs.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дендритные клетки</kwd><kwd>апоптоз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>B7-H1</kwd><kwd>IL-10</kwd><kwd>B7-H1</kwd><kwd>dendritic cells</kwd><kwd>apoptosis</kwd><kwd>IL-10</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Сахно Л.В., Распай Ж.М., Тихонова М.А. Дефект антигенпрезентирующих клеток у больных туберкулезом легких // Мед. иммунология. -2009. - Т. 11, № 2-3. - С. 245-254.</mixed-citation><mixed-citation xml:lang="en">Сахно Л.В., Распай Ж.М., Тихонова М.А. Дефект антигенпрезентирующих клеток у больных туберкулезом легких // Мед. иммунология. -2009. - Т. 11, № 2-3. - С. 245-254.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Сахно Л.В., Тихонова М.А., Леплина О.Ю. Роль PD-1/B7-H1-опосредованного пути в нарушении антигенспецифического ответа у больных туберкулезом легких // Иммунология. - 2011. -Т. 32. - С. 89-93.</mixed-citation><mixed-citation xml:lang="en">Сахно Л.В., Тихонова М.А., Леплина О.Ю. Роль PD-1/B7-H1-опосредованного пути в нарушении антигенспецифического ответа у больных туберкулезом легких // Иммунология. - 2011. -Т. 32. - С. 89-93.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Curiel T.J., Wei S., Dong H., Alvarez X. et al. Blockade of B7-H1 improves myeloid dendritic cell- mediated antitumor immunity // Nat Med. - 2003. -Vol. 9. - P. 562-567.</mixed-citation><mixed-citation xml:lang="en">Curiel T.J., Wei S., Dong H., Alvarez X. et al. Blockade of B7-H1 improves myeloid dendritic cell- mediated antitumor immunity // Nat Med. - 2003. -Vol. 9. - P. 562-567.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dong H., Chen X. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses // Cell. Mol. Immunology. - 2006. - Vol. 3. - P. 179-187.</mixed-citation><mixed-citation xml:lang="en">Dong H., Chen X. Immunoregulatory role of B7-H1 in chronicity of inflammatory responses // Cell. Mol. Immunology. - 2006. - Vol. 3. - P. 179-187.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Selenko-Gebauer N., Majdic O., Szekeres A., Hofler G. et al. B7-H1 (Programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy // J. Immunol. - 2003. -Vol. 170. - P. 3637-3644.</mixed-citation><mixed-citation xml:lang="en">Selenko-Gebauer N., Majdic O., Szekeres A., Hofler G. et al. B7-H1 (Programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy // J. Immunol. - 2003. -Vol. 170. - P. 3637-3644.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sharpe A.H., Wherry E.J., Ahmed R., Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection // Nature Immunology. - 2007. - Vol. 8. - P. 239-245.</mixed-citation><mixed-citation xml:lang="en">Sharpe A.H., Wherry E.J., Ahmed R., Freeman G.J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection // Nature Immunology. - 2007. - Vol. 8. - P. 239-245.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wesa A.K., Storkus W.J. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer // Cell Death and Differentiation. - 2008. -Vol. 15. - P. 51-57.</mixed-citation><mixed-citation xml:lang="en">Wesa A.K., Storkus W.J. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer // Cell Death and Differentiation. - 2008. -Vol. 15. - P. 51-57.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
